Cancer Center of Acadiana at Lafayette General Medical Center is seeking men and women, 18 and older, diagnosed with chronic phase myelogenous leukemia to participate in a clinical trial to compare experimental drug treatments with current treatments in newly diagnosed adult CPL patients.

The research study is being conducted at multiple hospitals across the country. No placebos will be administered because the trial will help determine the best course of treatment.

The study is a Phase III clinical trial, and if the drugs successfully pass Phase III, they may be approved for use in the general population.

The Cancer Center of Acadiana participates in clinical trials and studies to help improve patient care and disease prevention, hospital officials said in a news release.

There are other benefits — such as access to emerging treatments while helping researchers identify the best ways to treat cancer, hospital officials said.

Cancer Center of Acadiana staff will explain the potential risks and benefits of this specific study and also closely monitor and assess a patient’s progress during the clinical trial. The patient also will receive follow-up care.

For information on this and other clinical trials available at Lafayette General Medical Center, call (337) 289-8658 or visit l afayettegeneral.com/clinicaltrials.